CanaQuest Medical Corp.
CanaQuest Medical Corp. (CANQF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
canqf · pe ratio · data through Mar 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for CanaQuest Medical Corp. (CANQF) measures how much investors pay for each dollar of the company's trailing earnings. CANQF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.09.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-03-31
PE Ratio History
2013 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
CanaQuest Medical Corp.You CANQF | $0M | N/A | — | -$0.09 |
 BZAM Ltd. BZAMF | $0M | N/A | — | -$0.41 |
 Cotinga Pharmaceuticals Inc. COTQF | $0M | N/A | — | -$0.09 |
 ETAO International Co., Ltd. ETAOF | $0M | N/A | — | -$169.64 |
 Genex Pharmaceutical, Inc. GENX | $0M | 15.11x | — | $0.02 |
 Longport, Inc. LPTI | $0M | N/A | — | — |
 Greenwind Holdings Inc. NEWG | $0M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-03-31Latest FY2024 | — | $-0.09 | — | |
2023-03-31 FY2023 | — | $-0.05 | — | |
2022-03-31 FY2022 | — | $-0.04 | — | |
2021-03-31 FY2021 | — | $-0.01 | — | |
2020-03-31 FY2020 | — | $-0.06 | — | |
2019-03-31 FY2019 | — | $-0.06 | — | |
2018-03-31 FY2018 | — | $-0.08 | — | |
2017-03-31 FY2017 | — | $-0.23 | — | |
2016-03-31 FY2016 | — | $-0.20 | — | |
2015-03-31 FY2015 | — | $-0.12 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for CanaQuest Medical Corp. (CANQF) measures how much investors pay for each dollar of the company's trailing earnings. CANQF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.09.
Frequently asked questions
CANQF pe ratio · 6 questionsCANQF's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$0.09. Data sourced from Financial Modeling Prep via CANQF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CanaQuest Medical Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08